These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2938055)

  • 1. Beta endorphin enhances in vitro lymphokine production in patients with squamous carcinoma of the head and neck.
    Wolf GT; Peterson KA
    Otolaryngol Head Neck Surg; 1986 Feb; 94(2):224-9. PubMed ID: 2938055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma.
    Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR
    Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma.
    Beauchamp ML; Wolf GT
    Head Neck Surg; 1988; 10(3):187-94. PubMed ID: 3069811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma.
    Wolf GT; Peterson KA; Lovett EJ
    Head Neck Surg; 1985; 7(5):350-6. PubMed ID: 3879957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
    Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
    Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of impaired leukocyte migration inhibition by thymosin in patients with head and neck squamous carcinoma.
    Wolf GT; Kerney SE; Chretien PB
    Am J Surg; 1980 Oct; 140(4):531-7. PubMed ID: 6999927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient lymphokine production of newborn lymphocytes.
    Winter HS; Gard SE; Fischer TJ; Bryson YJ; Stiehm ER
    Pediatr Res; 1983 Jul; 17(7):573-8. PubMed ID: 6225985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte regulation of lymphokine production in cancer patients.
    Kowalczyk D; Ruggiero I; Zembala M
    J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors.
    Bailet JW; Lichtenstein A; Chen G; Mickel RA
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):855-62. PubMed ID: 9260552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
    Brown SL; Van Epps DE
    J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck.
    Wanebo HJ; Jones T; Pace R; Cantrell R; Levine P
    Am J Surg; 1989 Oct; 158(4):356-60. PubMed ID: 2802041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of distinct sites of beta-endorphin that stimulate lymphokine production by murine CD4+ T cells.
    Van den Bergh P; Rozing J; Nagelkerken L
    Lymphokine Cytokine Res; 1994 Apr; 13(2):63-9. PubMed ID: 7914752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. I. Effect of various metabolic inhibitors.
    Bendtzen K; Mahoney R; Rocklin RE
    Clin Immunol Immunopathol; 1981 Feb; 18(2):212-20. PubMed ID: 7008991
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of monokines in antigen- and lectin-induced human lymphokine production.
    Petersen J; Bendtzen K
    Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):229-35. PubMed ID: 6753485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of leucocyte migration inhibitory factor by lymphocytes in exudative pleural effusions.
    Pettersson T; Welin MG; Weber TH
    J Clin Lab Immunol; 1982 Jun; 8(2):107-11. PubMed ID: 7050387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides.
    Bendtzen K; Mahoney R; Rocklin RE
    Clin Immunol Immunopathol; 1981 Feb; 18(2):221-9. PubMed ID: 6258834
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of beta-endorphin and myelopeptides on the cAMP level and proliferation of lymphocytes in vitro].
    Zozulia AA; Patsakova E; Kost NV; Ivanushkin AM; Voronkova TL
    Biull Eksp Biol Med; 1986 Dec; 102(12):731-3. PubMed ID: 3026514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.